Abstract 2118: SGN-CEACAM5C/SAR445953, a novel topoisomerase I inhibitor antibody-drug conjugate targeting CEACAM5, has potent anti-tumor activity in CRC, PDAC, GC and lung cancer tumor models
Baudat, Yves, Nicolazzi, Celine, Sigurjonsson, Johann Petur, Amara, Celine, Clarke, Astrid, lyski, Ryan, Meyer, Dave, Fantin, Valeria, Chiron, Marielle, Decary, Stephanie
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 4890: A novel topoisomerase I inhibitor antibody-drug conjugate targeting CEACAM5 has potent anti-tumor activity in colorectal cancer models
Baudat, Yves, Neff-LaFord, Haley, Nicolazzi, Celine, Meyer, Dave, Sigurjonsson, Johann Petur, Lyski, Ryan, Fantin, Valeria, Brun, Marie-Priscille, Chiron, Marielle, Decary, Stephanie
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article